or
forgot password
  • cancer clinical trials in sayre, PA

  • Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Guthrie Cancer Center at Guthrie Clinic Sayre
    Sayre, Pennsylvania 18840
    Breast Cancer
    Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas
    Guthrie Cancer Center at Guthrie Clinic Sayre
    Sayre, Pennsylvania 18840
    Brain and Central Nervous System Tumors
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Guthrie Cancer Center at Guthrie Clinic Sayre
    Sayre, Pennsylvania 18840
    Lung Cancer
    Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer
    Guthrie Cancer Center at Guthrie Clinic Sayre
    Sayre, Pennsylvania 18840
    Head and Neck Cancer
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Guthrie Cancer Center at Guthrie Clinic Sayre
    Sayre, Pennsylvania 18840
    Esophageal Cancer, Gastric Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Guthrie Cancer Center at Guthrie Clinic Sayre
    Sayre, Pennsylvania 18840
    Breast Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    Guthrie Cancer Center at Guthrie Clinic Sayre
    Sayre, Pennsylvania 18840
    Breast Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Guthrie Cancer Center at Guthrie Clinic Sayre
    Sayre, Pennsylvania 18840
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Guthrie Clinic - Sayre
    Sayre, Pennsylvania 18840
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Study of Long-Term Peg Intron Vs. Colchicine in Non-Responders.
    Guthrie Research Foundation
    Sayre, Pennsylvania 18840
    Hepatitis C Virus, Advanced Fibrosis, Cirrhosis
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Guthrie Clinic-Robert Packer Hospital
    Sayre, Pennsylvania 18840
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Guthrie Cancer Center at Guthrie Clinic Sayre
    Sayre, Pennsylvania 18840
    Colorectal Cancer
    Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
    Guthrie Cancer Center at Guthrie Clinic Sayre
    Sayre, Pennsylvania 18840
    Breast Cancer, Cancer Survivor, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Sexuality and Reproductive Issues, Spiritual Concerns
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Guthrie Clinic-Robert Packer Hospital
    Sayre, Pennsylvania 18840
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Guthrie Clinic-Robert Packer Hospital
    Sayre, Pennsylvania 18840
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Guthrie Clinic-Robert Packer Hospital
    Sayre, Pennsylvania 18840
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Guthrie Cancer Center at Guthrie Clinic Sayre
    Sayre, Pennsylvania 18840
    Prostate Cancer
    S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
    Guthrie Cancer Center at Guthrie Clinic Sayre
    Sayre, Pennsylvania 18840
    Breast Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Guthrie Clinic-Robert Packer Hospital
    Sayre, Pennsylvania 18840
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Guthrie Cancer Center at Guthrie Clinic Sayre
    Sayre, Pennsylvania 18840
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Guthrie Clinic-Robert Packer Hospital
    Sayre, Pennsylvania 18840
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Guthrie Clinic-Robert Packer Hospital
    Sayre, Pennsylvania 18840
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Guthrie Clinic-Robert Packer Hospital
    Sayre, Pennsylvania 18840
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer
    Guthrie Clinic, Ltd
    Sayre, Pennsylvania 18840
    Non-small Cell Lung Cancer (NSCLC)
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Guthrie Clinic-Robert Packer Hospital
    Sayre, Pennsylvania 18840
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Guthrie Clinic-Robert Packer Hospital
    Sayre, Pennsylvania 18840
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
    Guthrie Clinic
    Sayre, Pennsylvania 18840
    Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Guthrie Clinic-Robert Packer Hospital
    Sayre, Pennsylvania 18840
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
    Guthrie Cancer Center at Guthrie Clinic Sayre
    Sayre, Pennsylvania 18840
    Melanoma (Skin)
    Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
    Guthrie Cancer Center at Guthrie Clinic Sayre
    Sayre, Pennsylvania 18840
    Chemotherapeutic Agent Toxicity, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Pain, Peripheral Neuropathy, Primary Peritoneal Cavity Cancer
    Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
    Guthrie Cancer Center at Guthrie Clinic Sayre
    Sayre, Pennsylvania 18840
    Breast Cancer, Cardiac Toxicity
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Guthrie Clinic-Robert Packer Hospital
    Sayre, Pennsylvania 18840
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
    Guthrie Clinic, Ltd
    Sayre, Pennsylvania 18840
    Peripheral T-cell Lymphoma
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Guthrie Cancer Center at Guthrie Clinic Sayre
    Sayre, Pennsylvania 18840
    Kidney Cancer
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Guthrie Clinic-Robert Packer Hospital
    Sayre, Pennsylvania 18840
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Guthrie Clinic-Robert Packer Hospital
    Sayre, Pennsylvania 18840
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Guthrie Clinic-Robert Packer Hospital
    Sayre, Pennsylvania 18840
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
    Donald Guthrie Foundation for Education and Research
    Sayre, Pennsylvania 18840
    Ulcerative Colitis
    A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors
    Robert Packer Hospital

    Trial Locations
    Robert Packer Hospital
    Guthrie Clinic, Ltd.
    Well-differentiated Pancreatic Neuroendocrine Tumor
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    Guthrie Clinic-Robert Packer Hospital
    Sayre, Pennsylvania 18840
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Guthrie Medical Center - Sayre
    Sayre, Pennsylvania 18840
    Anal Cancer
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Guthrie Cancer Center at Guthrie Clinic Sayre
    Sayre, Pennsylvania 18840
    Melanoma (Skin)
    Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
    Guthrie Medical Center
    Sayre, Pennsylvania 18840
    Lymphoma
    Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer
    Guthrie Medical Center - Sayre
    Sayre, Pennsylvania 18840
    Kidney Cancer
    Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
    Guthrie Medical Center - Sayre
    Sayre, Pennsylvania 18840
    Leukemia, Myelodysplastic Syndromes
    Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
    Guthrie Cancer Center at Guthrie Clinic Sayre
    Sayre, Pennsylvania 18840
    Colorectal Cancer, Metastatic Cancer
    Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
    Guthrie Medical Center - Sayre
    Sayre, Pennsylvania 18840
    Pancreatic Cancer
    Phase II CT-2103/Carboplatin in Ovarian Cancer
    Guthrie Foundation for Education and Research
    Sayre, Pennsylvania 18840
    Ovarian Neoplasm
    Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Robert Packer Hospital

    Trial Locations
    Robert Packer Hospital
    Guthrie Clinic
    Non Small Cell Lung Carcinoma
    First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
    Guthrie Foundation for Education and Research
    Sayre, Pennsylvania 18840
    Bladder Cancer, Transitional Cell Carcinoma, Metastasis
    Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis
    Site Ref # / Investigator 3765
    Sayre, Pennsylvania 18840
    Ulcerative Colitis
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Guthrie Clinic Ltd.
    Sayre, Pennsylvania 18840
    Atrial Fibrillation, Atrial Flutter